Steven B. Kanner
Dr. Steven B. Kanner is a Chief Scientific Officer at Caribou Biosciences, Inc. Dr. Kanner was previously employed as a Vice President-Biology by Arrowhead Pharmaceuticals, Inc. He received his undergraduate degree from the University of California, Berkeley and a doctorate degree from the University of Miami.
Transactions
Date
Transaction
Value
| 05/13/2022 | 6,114 | Derivative/Non-derivative trans. at $2.69 per share. | 16,446 |
| 05/13/2022 | 68,306 | Derivative/Non-derivative trans. at $1.81 per share. | 123,633 |
| 03/04/2022 | 1,549 | Derivative/Non-derivative trans. at $4.11 per share. | 6,366 |
| 03/04/2022 | 9,171 | Derivative/Non-derivative trans. at $2.69 per share. | 24,669 |
| 10/12/2021 | 14,614 | Acquisition at $2.69 per share. | 39,311 |
| 10/12/2021 | 698 | Acquisition at $1.81 per share. | 1,263 |
| 10/12/2021 | 99,548 | Acquisition at $1.81 per share. | 180,181 |
